AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Scope & Guideline

Bridging Research and Practice in Dermatology

Introduction

Explore the comprehensive scope of AMERICAN JOURNAL OF CLINICAL DERMATOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore AMERICAN JOURNAL OF CLINICAL DERMATOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1175-0561
PublisherADIS INT LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2000 to 2024
AbbreviationAM J CLIN DERMATOL / Am. J. Clin. Dermatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND

Aims and Scopes

The American Journal of Clinical Dermatology aims to provide a comprehensive platform for the dissemination of advanced knowledge in dermatology, emphasizing clinical practice and research. The journal covers a wide range of topics pertinent to the field, including treatment efficacy, disease mechanisms, and patient-centered care.
  1. Clinical Efficacy and Safety of Treatments:
    The journal frequently publishes studies evaluating the clinical efficacy and safety of various dermatological treatments, including biologics, JAK inhibitors, and traditional therapies, using randomized controlled trials and real-world evidence.
  2. Innovative Diagnostic and Therapeutic Approaches:
    Research on innovative diagnostic techniques and therapeutic strategies, particularly in the context of emerging technologies like artificial intelligence and personalized medicine, is a consistent focus.
  3. Pathophysiology of Skin Diseases:
    The journal emphasizes understanding the underlying mechanisms of various skin diseases, including autoimmune conditions, inflammatory disorders, and skin cancers, providing insights that inform treatment.
  4. Patient-Centered Care and Quality of Life:
    The journal highlights the importance of patient-reported outcomes and quality of life in dermatological practice, advocating for approaches that consider the holistic impact of skin diseases on patients.
  5. Emerging Trends in Dermatology:
    The publication regularly addresses emerging trends and challenges in dermatology, including the impact of systemic diseases on skin health, the role of comorbidities, and the implications of climate change on dermatologic conditions.
The American Journal of Clinical Dermatology is witnessing a dynamic evolution in its research themes, reflecting the latest advancements and challenges in dermatology. Emerging scopes indicate a shift towards more innovative and integrative approaches to skin health.
  1. Biologics and Targeted Therapies:
    There is a significant increase in research dedicated to biologics and targeted therapies, particularly for chronic conditions like psoriasis and atopic dermatitis, highlighting their clinical efficacy and safety in diverse patient populations.
  2. Artificial Intelligence in Dermatology:
    The integration of artificial intelligence in diagnostic processes and patient management is on the rise, showcasing its potential to transform dermatological practices through enhanced accuracy and efficiency.
  3. Impact of Comorbidities on Skin Diseases:
    Emerging studies are increasingly exploring the relationship between skin conditions and systemic comorbidities, reflecting a growing understanding of how overall health influences dermatological outcomes.
  4. Personalized Medicine Approaches:
    There is a trend towards personalized medicine in dermatology, with research focusing on tailoring treatments based on individual patient characteristics, including genetic profiles and specific disease presentations.
  5. Psychosocial Aspects and Quality of Life:
    An increasing emphasis on the psychosocial aspects of skin diseases, including their impact on quality of life and mental health, indicates a broader approach to patient care that goes beyond physical symptoms.

Declining or Waning

While the journal maintains a robust focus on numerous vital areas in dermatology, certain themes have experienced a decline in prominence over recent years. These waning scopes reflect shifting priorities in research and clinical practice.
  1. Traditional Therapeutics:
    There is a noticeable decrease in publications centered around traditional dermatological treatments, such as topical corticosteroids and older systemic therapies, as newer biologics and targeted therapies gain attention.
  2. General Reviews without New Insights:
    General literature reviews lacking novel insights or updates on treatment paradigms have become less common, as the journal increasingly favors studies that present original research findings or significant advances.
  3. Epidemiological Studies of Common Conditions:
    Research focusing on the epidemiology of common dermatological conditions appears to be waning, possibly due to a shift toward more specific and mechanistic studies that delve deeper into pathophysiology.
  4. Pharmacovigilance Studies:
    Although important, studies focused solely on pharmacovigilance and adverse event reporting are less frequently featured, as the journal prioritizes comprehensive clinical trials and real-world efficacy studies.

Similar Journals

Postepy Dermatologii i Alergologii

Exploring the forefront of skin and immune health.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1642-395XFrequency: 6 issues/year

Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.

Dermatologic Therapy

Connecting researchers and clinicians to enhance skin therapy.
Publisher: WILEY-HINDAWIISSN: 1396-0296Frequency: 1 issue/year

Dermatologic Therapy is a leading peer-reviewed journal published by WILEY-HINDAWI that focuses on the multifaceted field of dermatology. Established in 1996 and continuing its profound impact into 2024, the journal has earned an impressive Q1 rating in Dermatology and ranks 11th out of 142 in the Scopus categorization, placing it in the 92nd percentile. With its headquarters in the United Kingdom, the journal's mission is to advance the understanding and treatment of skin diseases through the dissemination of high-quality research, reviews, and clinical information. Although not an open-access journal, it provides extensive access options to ensure that vital research reaches its audience. By leading scholarly discourse and innovation in dermatological treatments, Dermatologic Therapy serves as an essential resource for researchers, clinicians, and students dedicated to improving skin health worldwide.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Pioneering Research in Dermatology and Venereology
Publisher: MASSON EDITEURISSN: 0151-9638Frequency: 12 issues/year

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE is a distinguished journal that serves as a vital platform for disseminating innovative research and insightful reviews in the field of dermatology and venereology. Published by MASSON EDITEUR, this journal has been a cornerstone for professionals and researchers since its inception in 1977, offering a wealth of knowledge that spans decades. With its ISSN 0151-9638 and E-ISSN 2214-5451, it is indexed within leading databases, ensuring that the published work reaches a broad audience. The journal currently holds a Q3 ranking in the dermatology category, reflecting its commitment to quality and rigorous peer-review processes. While the journal is not open access, it provides an extensive archive of valuable studies that contribute to advancements in skin health and treatment methodologies. Located in Issy-les-Moulineaux, France, ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE continues to attract submissions from esteemed professionals, enhancing its reputation as a crucial resource for those dedicated to the ongoing development of dermatological sciences.

Nature Reviews Rheumatology

Transforming insights into improved patient care.
Publisher: NATURE PORTFOLIOISSN: 1759-4790Frequency: 12 issues/year

Nature Reviews Rheumatology is a premier academic journal published by NATURE PORTFOLIO, dedicated to the field of rheumatology. With an impressive impact factor reflecting its high citation rate and relevance within the scientific community, it ranks in the Q1 category for rheumatology, showcasing its essential role in disseminating cutting-edge research and reviews. The journal serves as a vital resource for researchers, clinicians, and students alike, presenting comprehensive articles that cover the latest developments, therapeutic advancements, and emerging trends in rheumatic diseases. With access options, including open access, it ensures that valuable insights are within reach for all stakeholders in the field. Situated in the United Kingdom and intersecting with a global audience, Nature Reviews Rheumatology stands as an authoritative voice, fostering education and innovation to improve patient outcomes and enhance the understanding of rheumatological conditions.

Journal of Cutaneous Immunology and Allergy

Connecting experts to enhance the dialogue in dermatology and immunology.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 6 issues/year

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Empowering skin health through groundbreaking research.
Publisher: MOSBY-ELSEVIERISSN: 0190-9622Frequency: 12 issues/year

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, published by Mosby-Elsevier, stands at the forefront of dermatological research and education. With an impressive impact factor and categorized as Q1 in Dermatology, this journal has established itself as a pivotal resource for healthcare professionals and researchers in the field. Since its inception in 1979, it has provided a platform for high-quality peer-reviewed articles, contributing significantly to advancements in dermatological science and practice through 2024. The journal commands an honorable position, ranking #8 out of 142 in the Scopus database's medicine dermatology category, placing it in the 94th percentile among its peers. Readers can access a wealth of cutting-edge studies, case reports, and reviews that address a broad spectrum of topics, from clinical dermatology to emerging therapies. In addition, the journal's commitment to excellence ensures it remains an essential tool for students, clinicians, and researchers dedicated to improving skin health and furthering knowledge in dermatology.

JOURNAL OF DERMATOLOGY

Shaping the future of skin health through impactful research.
Publisher: WILEYISSN: 0385-2407Frequency: 12 issues/year

The Journal of Dermatology, published by Wiley, is a premier academic journal dedicated to advancing the field of dermatology, with its esteemed reputation reflected in its Q1 ranking in Dermatology and a remarkable Q2 ranking in Miscellaneous Medicine as of 2023. Since its inception in 1974, the journal has become a vital resource for researchers, clinicians, and students alike, covering pioneering studies and cutting-edge advancements in skin health and disease. With a Scopus rank of #32 out of 142 in the Dermatology category, placing it in the 77th percentile, the journal underscores its commitment to fostering knowledge and innovation within the dermatological community. Although the journal operates under a subscription model, it remains an essential platform for disseminating impactful research that shapes clinical practice and enhances patient care. For anyone invested in dermatological sciences, Journal of Dermatology serves as a key publication where critical insights and developments are regularly showcased.

CLINICAL AND EXPERIMENTAL DERMATOLOGY

Illuminating the Path to Better Skin Care Practices.
Publisher: OXFORD UNIV PRESSISSN: 0307-6938Frequency: 12 issues/year

CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.

BRITISH JOURNAL OF DERMATOLOGY

Exploring the frontiers of skin science and treatment.
Publisher: OXFORD UNIV PRESSISSN: 0007-0963Frequency: 12 issues/year

The British Journal of Dermatology, published by Oxford University Press, stands as a premier platform for advancing the field of dermatological research and clinical practice since its inception in 1892. With a strong commitment to disseminating high-quality research, this esteemed journal is currently ranked in the Q1 category for both Dermatology and Miscellaneous Medicine in 2023, reflecting its influential position in the academic landscape. As the leading journal in its field, it enjoys a robust Scopus ranking of #1 out of 142 in dermatology, placing it in the 99th percentile globally. The journal covers a wide scope of subjects pertinent to dermatology, including clinical trials, treatment innovations, and epidemiological studies, making it an essential resource for researchers, healthcare professionals, and students alike. Although it is not an open-access publication, it ensures a broad reach through institutional subscriptions, fostering knowledge exchange across the global dermatological community. Based in the heart of the United Kingdom, the British Journal of Dermatology continues to play a crucial role in shaping the future of skin health and disease management.

EXPERIMENTAL DERMATOLOGY

Advancing the Science of Skin Health
Publisher: WILEYISSN: 0906-6705Frequency: 12 issues/year

EXPERIMENTAL DERMATOLOGY, published by WILEY, is a leading journal in the fields of Biochemistry and Dermatology, with impressive rankings including Q1 status in both categories as of 2023. With its ISSN 0906-6705 and E-ISSN 1600-0625, the journal offers a reputable platform for disseminating cutting-edge research and insights into skin biology and related health issues. As a pivotal resource for professionals, researchers, and students alike, EXPERIMENTAL DERMATOLOGY includes a broad scope of topics, fostering a deeper understanding of dermatological conditions and enhancing new therapeutic strategies. The journal’s distinguished performance is highlighted by its Scopus rankings, which place it at the 91st percentile in Medicine-Dermatology and the 65th in Biochemistry. While not an open-access publication, the journal remains committed to ensuring the accessibility of crucial developments within the dermatological community worldwide, facilitating the advancement of both clinical practice and academic inquiry.